Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment.
about
Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine ModelOral squamous cell carcinoma in a patient treated with long-term pegylated liposomal doxorubicin for recurrent ovarian cancer.Improvement of the pharmacokinetics and in vivo antibacterial efficacy of a novel type IIa topoisomerase inhibitor by formulation in liposomes.Synthesis and characterization of folate-targeted dextran/retinoic acid micelles for doxorubicin delivery in acute leukemia.Cardiotoxicity evaluation of anthracyclines in zebrafish (Danio rerio).
P2860
Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic and toxicity c ...... s in ovarian cancer treatment.
@en
Pharmacokinetic and toxicity c ...... s in ovarian cancer treatment.
@nl
type
label
Pharmacokinetic and toxicity c ...... s in ovarian cancer treatment.
@en
Pharmacokinetic and toxicity c ...... s in ovarian cancer treatment.
@nl
prefLabel
Pharmacokinetic and toxicity c ...... s in ovarian cancer treatment.
@en
Pharmacokinetic and toxicity c ...... s in ovarian cancer treatment.
@nl
P2093
P2860
P1476
Pharmacokinetic and toxicity c ...... s in ovarian cancer treatment.
@en
P2093
Mario Valenzano Menada
Matteo Morotti
Pier Luigi Venturini
Simone Ferrero
P2860
P304
P356
10.1517/17425255.2011.570330
P407
P577
2011-03-24T00:00:00Z